{
"info": {
"nct_id": "NCT00144131",
"official_title": "Flexibility: A Study to Assess the Impact of Once Per Cycle Correction and Maintenance Dosing of Darbepoetin Alfa in Subjects With Non-Myeloid Malignancies With Anemia Due to Chemotherapy",
"inclusion_criteria": "- Subjects with active non-myeloid malignancy(ies) including lymphocytic leukemias - Receiving chemotherapy and expected to receive at least 8 additional weeks of cyclic cytotoxic chemotherapy anticipated to be on a QW, every other week (Q2W) or every three weeks (Q3W) schedule - Anemia due to cancer and/or chemotherapy (screening Hb less than 11.0 g/dL) - Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "- Subjects with acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), or myelodysplastic syndromes (MDS) - Other underlying hematologic disorder, which could cause anemia, other than a non-myeloid malignancy - Active bleeding - Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis) - Active, unstable systemic or chronic infection - Planned elective surgery during the study where significant blood loss is expected - Known iron deficiency (to be considered iron deficient a subject must have both of the following: a saturated transferrin less than 15% and ferritin less than 10 ng/mL at screening) - Unstable angina, or uncontrolled cardiac arrhythmia - Hypertension (diastolic blood pressure greater than 100 mmHg) - Inadequate renal and/or liver function (e.g., creatinine greater than 2 X upper limit of normal (ULN) and/or transaminase greater than 5 X ULN) - History of pure red blood cell aplasia - Known positive human immunodeficiency virus (HIV) test or acquired immune deficiency syndrome (AIDS) status - Known positive antibody response to any erythropoietic agent - Subject has known sensitivity to any erythropoietic agents, the study drug, or its excipients to be administered during this study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "- Subjects with active non-myeloid malignancy(ies) including lymphocytic leukemias - Receiving chemotherapy and expected to receive at least 8 additional weeks of cyclic cytotoxic chemotherapy anticipated to be on a QW, every other week (Q2W) or every three weeks (Q3W) schedule - Anemia due to cancer and/or chemotherapy (screening Hb less than 11.0 g/dL) - Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2",
"criterions": [
{
"exact_snippets": "active non-myeloid malignancy(ies) including lymphocytic leukemias",
"criterion": "active non-myeloid malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Receiving chemotherapy and expected to receive at least 8 additional weeks of cyclic cytotoxic chemotherapy",
"criterion": "chemotherapy treatment duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
},
{
"exact_snippets": "cyclic cytotoxic chemotherapy anticipated to be on a QW, every other week (Q2W) or every three weeks (Q3W) schedule",
"criterion": "chemotherapy schedule",
"requirement": {
"requirement_type": "schedule",
"expected_value": [
"QW",
"Q2W",
"Q3W"
]
}
},
{
"exact_snippets": "Anemia due to cancer and/or chemotherapy (screening Hb less than 11.0 g/dL)",
"criterion": "anemia",
"requirement": {
"requirement_type": "hemoglobin level",
"expected_value": {
"operator": "<",
"value": 11.0,
"unit": "g/dL"
}
}
},
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "active non-myeloid malignancy(ies) including lymphocytic leukemias",
"criterion": "active non-myeloid malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Receiving chemotherapy and expected to receive at least 8 additional weeks of cyclic cytotoxic chemotherapy",
"criterion": "chemotherapy treatment duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
}
]
},
{
"exact_snippets": "cyclic cytotoxic chemotherapy anticipated to be on a QW, every other week (Q2W) or every three weeks (Q3W) schedule",
"criterion": "chemotherapy schedule",
"requirement": {
"requirement_type": "schedule",
"expected_value": [
"QW",
"Q2W",
"Q3W"
]
}
}
]
},
{
"exact_snippets": "Anemia due to cancer and/or chemotherapy (screening Hb less than 11.0 g/dL)",
"criterion": "anemia",
"requirement": {
"requirement_type": "hemoglobin level",
"expected_value": {
"operator": "<",
"value": 11.0,
"unit": "g/dL"
}
}
}
]
},
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "- Subjects with acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), or myelodysplastic syndromes (MDS) - Other underlying hematologic disorder, which could cause anemia, other than a non-myeloid malignancy - Active bleeding - Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis) - Active, unstable systemic or chronic infection - Planned elective surgery during the study where significant blood loss is expected - Known iron deficiency (to be considered iron deficient a subject must have both of the following: a saturated transferrin less than 15% and ferritin less than 10 ng/mL at screening) - Unstable angina, or uncontrolled cardiac arrhythmia - Hypertension (diastolic blood pressure greater than 100 mmHg) - Inadequate renal and/or liver function (e.g., creatinine greater than 2 X upper limit of normal (ULN) and/or transaminase greater than 5 X ULN) - History of pure red blood cell aplasia - Known positive human immunodeficiency virus (HIV) test or acquired immune deficiency syndrome (AIDS) status - Known positive antibody response to any erythropoietic agent - Subject has known sensitivity to any erythropoietic agents, the study drug, or its excipients to be administered during this study",
"criterions": [
{
"exact_snippets": "acute myelogenous leukemia (AML)",
"criterion": "acute myelogenous leukemia (AML)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "chronic myelogenous leukemia (CML)",
"criterion": "chronic myelogenous leukemia (CML)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "myelodysplastic syndromes (MDS)",
"criterion": "myelodysplastic syndromes (MDS)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Other underlying hematologic disorder, which could cause anemia, other than a non-myeloid malignancy",
"criterion": "underlying hematologic disorder",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Active bleeding",
"criterion": "active bleeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Active, unstable systemic or chronic infection",
"criterion": "systemic or chronic infection",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "Active, unstable systemic or chronic infection",
"criterion": "systemic or chronic infection",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Planned elective surgery during the study where significant blood loss is expected",
"criterion": "planned elective surgery",
"requirement": {
"requirement_type": "timing",
"expected_value": "during the study"
}
},
{
"exact_snippets": "Planned elective surgery during the study where significant blood loss is expected",
"criterion": "planned elective surgery",
"requirement": {
"requirement_type": "expected blood loss",
"expected_value": "significant"
}
},
{
"exact_snippets": "Known iron deficiency ... saturated transferrin less than 15% and ferritin less than 10 ng/mL",
"criterion": "iron deficiency",
"requirement": {
"requirement_type": "saturated transferrin",
"expected_value": {
"operator": "<",
"value": 15,
"unit": "%"
}
}
},
{
"exact_snippets": "Known iron deficiency ... saturated transferrin less than 15% and ferritin less than 10 ng/mL",
"criterion": "iron deficiency",
"requirement": {
"requirement_type": "ferritin",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "ng/mL"
}
}
},
{
"exact_snippets": "Unstable angina",
"criterion": "unstable angina",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled cardiac arrhythmia",
"criterion": "uncontrolled cardiac arrhythmia",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Hypertension (diastolic blood pressure greater than 100 mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 100,
"unit": "mmHg"
}
}
},
{
"exact_snippets": "Inadequate renal and/or liver function ... creatinine greater than 2 X upper limit of normal (ULN)",
"criterion": "renal function",
"requirement": {
"requirement_type": "creatinine",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "X ULN"
}
}
},
{
"exact_snippets": "Inadequate renal and/or liver function ... transaminase greater than 5 X ULN",
"criterion": "liver function",
"requirement": {
"requirement_type": "transaminase",
"expected_value": {
"operator": ">",
"value": 5,
"unit": "X ULN"
}
}
},
{
"exact_snippets": "History of pure red blood cell aplasia",
"criterion": "pure red blood cell aplasia",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Known positive human immunodeficiency virus (HIV) test or acquired immune deficiency syndrome (AIDS) status",
"criterion": "HIV or AIDS status",
"requirement": {
"requirement_type": "test result",
"expected_value": "positive"
}
},
{
"exact_snippets": "Known positive antibody response to any erythropoietic agent",
"criterion": "antibody response to erythropoietic agent",
"requirement": {
"requirement_type": "test result",
"expected_value": "positive"
}
},
{
"exact_snippets": "Subject has known sensitivity to any erythropoietic agents, the study drug, or its excipients",
"criterion": "sensitivity to erythropoietic agents or study drug",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "acute myelogenous leukemia (AML)",
"criterion": "acute myelogenous leukemia (AML)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "chronic myelogenous leukemia (CML)",
"criterion": "chronic myelogenous leukemia (CML)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "myelodysplastic syndromes (MDS)",
"criterion": "myelodysplastic syndromes (MDS)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "Other underlying hematologic disorder, which could cause anemia, other than a non-myeloid malignancy",
"criterion": "underlying hematologic disorder",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Active bleeding",
"criterion": "active bleeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"and_criteria": [
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "Severe, unstable, active chronic inflammatory disease (e.g., ulcerative disease, peptic ulcer disease, rheumatoid arthritis)",
"criterion": "chronic inflammatory disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Active, unstable systemic or chronic infection",
"criterion": "systemic or chronic infection",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "Active, unstable systemic or chronic infection",
"criterion": "systemic or chronic infection",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Planned elective surgery during the study where significant blood loss is expected",
"criterion": "planned elective surgery",
"requirement": {
"requirement_type": "timing",
"expected_value": "during the study"
}
},
{
"exact_snippets": "Planned elective surgery during the study where significant blood loss is expected",
"criterion": "planned elective surgery",
"requirement": {
"requirement_type": "expected blood loss",
"expected_value": "significant"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Known iron deficiency ... saturated transferrin less than 15% and ferritin less than 10 ng/mL",
"criterion": "iron deficiency",
"requirement": {
"requirement_type": "saturated transferrin",
"expected_value": {
"operator": "<",
"value": 15,
"unit": "%"
}
}
},
{
"exact_snippets": "Known iron deficiency ... saturated transferrin less than 15% and ferritin less than 10 ng/mL",
"criterion": "iron deficiency",
"requirement": {
"requirement_type": "ferritin",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "ng/mL"
}
}
}
]
},
{
"exact_snippets": "Unstable angina",
"criterion": "unstable angina",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled cardiac arrhythmia",
"criterion": "uncontrolled cardiac arrhythmia",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Hypertension (diastolic blood pressure greater than 100 mmHg)",
"criterion": "hypertension",
"requirement": {
"requirement_type": "diastolic blood pressure",
"expected_value": {
"operator": ">",
"value": 100,
"unit": "mmHg"
}
}
},
{
"or_criteria": [
{
"exact_snippets": "Inadequate renal and/or liver function ... creatinine greater than 2 X upper limit of normal (ULN)",
"criterion": "renal function",
"requirement": {
"requirement_type": "creatinine",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "X ULN"
}
}
},
{
"exact_snippets": "Inadequate renal and/or liver function ... transaminase greater than 5 X ULN",
"criterion": "liver function",
"requirement": {
"requirement_type": "transaminase",
"expected_value": {
"operator": ">",
"value": 5,
"unit": "X ULN"
}
}
}
]
},
{
"exact_snippets": "History of pure red blood cell aplasia",
"criterion": "pure red blood cell aplasia",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Known positive human immunodeficiency virus (HIV) test or acquired immune deficiency syndrome (AIDS) status",
"criterion": "HIV or AIDS status",
"requirement": {
"requirement_type": "test result",
"expected_value": "positive"
}
},
{
"exact_snippets": "Known positive antibody response to any erythropoietic agent",
"criterion": "antibody response to erythropoietic agent",
"requirement": {
"requirement_type": "test result",
"expected_value": "positive"
}
},
{
"exact_snippets": "Subject has known sensitivity to any erythropoietic agents, the study drug, or its excipients",
"criterion": "sensitivity to erythropoietic agents or study drug",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}